SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-000319
Filing Date
2021-01-05
Accepted
2021-01-05 09:12:46
Documents
3
Period of Report
2021-01-05

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea132701-6k_therapixbio.htm 6-K 17180
2 PRESS RELEASE TITLED: "THERAPIX BIOSCIENCES AND CYNTAR VENTURES ENTERED A NON-BI ea132701ex99-1_therapixbio.htm EX-99.1 9845
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3722
  Complete submission text file 0001213900-21-000319.txt   33270
Mailing Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608
Business Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 21504091
SIC: 2834 Pharmaceutical Preparations